Journal
CURRENT MEDICINAL CHEMISTRY
Volume 26, Issue 9, Pages 1576-1593Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867325666180307114855
Keywords
lipoproteins; oxLDL; oxLDL/LDL ratio; oxidized phosphatidylcholine; AMI; periodontitis; GCF; transcytosis
Funding
- JSPS KAKENHI [15K07944, 24590094]
- MEXT
- Grants-in-Aid for Scientific Research [16K08245, 24590094, 15K07944] Funding Source: KAKEN
Ask authors/readers for more resources
Oxidatively modified low-density lipoprotein (oxLDL) is known to be involved in various diseases, including cardiovascular diseases. The presence of oxLDL in the human circulatory system and in atherosclerotic lesions has been demonstrated using monoclonal antibodies. Studies have shown the significance of circulating oxLDL in various systemic diseases, including acute myocardial infarction and diabetic mellitus. Several different enzyme-linked immunosorbent assay (ELISA) procedures to measure oxLDL were utilized. Evidence has been accumulating that reveals changes in oxLDL levels under certain pathological conditions. Since oxLDL concentration tends to correlate with low-density lipoprotein (LDL)-cholesterol, the ratio of ox-LDL and LDL rather than oxLDL concentration alone has also been focused. In addition to circulating plasma, LDL and oxLDL are found in gingival crevicular fluid (GCF), where the ratio of oxLDL to LDL in GCF is much higher than in plasma. LDL and oxLDL levels in GCF show an increase in diabetic patients and periodontal patients, suggesting that GCF might be useful in examining systemic conditions. GCF oxLDL increased when the teeth were affected by periodontitis. It is likely that oxLDL levels in plasma and GCF could reflect oxidative stress and transfer efficacy in the circulatory system.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available